186 related articles for article (PubMed ID: 20890611)
1. Erythropoietin: a novel treatment for traumatic optic neuropathy-a pilot study.
Kashkouli MB; Pakdel F; Sanjari MS; Haghighi A; Nojomi M; Homaee MH; Heirati A
Graefes Arch Clin Exp Ophthalmol; 2011 May; 249(5):731-6. PubMed ID: 20890611
[TBL] [Abstract][Full Text] [Related]
2. Erythropoietin as a treatment option for indirect traumatic optic neuropathy: A pilot study.
Kumar M; Kowsalya A; Narayanamoorthy J; Kumarasamy D; Chitradevi ; Balakrishnan H; Chaudhary S
Indian J Ophthalmol; 2023 Jan; 71(1):235-240. PubMed ID: 36588242
[TBL] [Abstract][Full Text] [Related]
3. A pilot study of the effect of intravenous erythropoetin on improvement of visual function in patients with recent indirect traumatic optic neuropathy.
Entezari M; Esmaeili M; Yaseri M
Graefes Arch Clin Exp Ophthalmol; 2014 Aug; 252(8):1309-13. PubMed ID: 24986593
[TBL] [Abstract][Full Text] [Related]
4. Traumatic optic neuropathy treatment trial (TONTT): open label, phase 3, multicenter, semi-experimental trial.
Kashkouli MB; Yousefi S; Nojomi M; Sanjari MS; Pakdel F; Entezari M; Etezad-Razavi M; Razeghinejad MR; Esmaeli M; Shafiee M; Bagheri M
Graefes Arch Clin Exp Ophthalmol; 2018 Jan; 256(1):209-218. PubMed ID: 28986670
[TBL] [Abstract][Full Text] [Related]
5. Steroids for traumatic optic neuropathy.
Yu-Wai-Man P; Griffiths PG
Cochrane Database Syst Rev; 2011 Jan; (1):CD006032. PubMed ID: 21249673
[TBL] [Abstract][Full Text] [Related]
6. The Effect of Combined Systemic Erythropoietin and Steroid on Non-arteritic Anterior Ischemic Optic Neuropathy: A Prospective Study.
Pakravan M; Esfandiari H; Hassanpour K; Razavi S; Pakravan P
Curr Eye Res; 2017 Jul; 42(7):1079-1084. PubMed ID: 28632028
[TBL] [Abstract][Full Text] [Related]
7. Erythropoietin as an adjunctive treatment for methanol-induced toxic optic neuropathy.
Pakravan M; Esfandiari H; Sanjari N; Ghahari E
Am J Drug Alcohol Abuse; 2016 Nov; 42(6):633-639. PubMed ID: 27463192
[TBL] [Abstract][Full Text] [Related]
8. Erythropoietin in Treatment of Methanol Optic Neuropathy.
Pakdel F; Sanjari MS; Naderi A; Pirmarzdashti N; Haghighi A; Kashkouli MB
J Neuroophthalmol; 2018 Jun; 38(2):167-171. PubMed ID: 29300238
[TBL] [Abstract][Full Text] [Related]
9. Clinical profile and visual outcome in patients with traumatic optic neuropathy.
Sujithra H; Shah K; Greeshma C
Indian J Ophthalmol; 2023 Aug; 71(8):3046-3052. PubMed ID: 37530279
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal erythropoietin injection in late-stage optic neuropathy: a safety study on human.
Acar U; Kucuk B; Sevinc MK; Aykas S; Erdurmus M; Sobaci G
Int Ophthalmol; 2018 Jun; 38(3):1021-1025. PubMed ID: 28527030
[TBL] [Abstract][Full Text] [Related]
11. High-dose intravenous methylprednisolone in recent traumatic optic neuropathy; a randomized double-masked placebo-controlled clinical trial.
Entezari M; Rajavi Z; Sedighi N; Daftarian N; Sanagoo M
Graefes Arch Clin Exp Ophthalmol; 2007 Sep; 245(9):1267-71. PubMed ID: 17265030
[TBL] [Abstract][Full Text] [Related]
12. [Erythropoietin protects retinal ganglion cells and visual function after ocular ischemia and optic nerve compression].
Jehle T; Meschede W; Dersch R; Feltgen N; Bach M; Lagrèze WA
Ophthalmologe; 2010 Apr; 107(4):347-53. PubMed ID: 19787355
[TBL] [Abstract][Full Text] [Related]
13. Risk Factor Analysis for the Outcomes of Indirect Traumatic Optic Neuropathy with No Light Perception at Initial Visual Acuity Testing.
Lai IL; Liao HT
World Neurosurg; 2018 Jul; 115():e620-e628. PubMed ID: 29705230
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcome after conservative treatment of indirect traumatic optic neuropathy.
Carta A; Ferrigno L; Leaci R; Kosmarikou A; Zola E; Gomarasca S
Eur J Ophthalmol; 2006; 16(6):847-50. PubMed ID: 17191191
[TBL] [Abstract][Full Text] [Related]
15. Visual-Evoked-Response-Supported Outcome of Intravitreal Erythropoietin in Management of Indirect Traumatic Optic Neuropathy.
Rashad MA; Abdel Latif AAM; Mostafa HA; Fawzy SM; Abdel Latif MAM
J Ophthalmol; 2018; 2018():2750632. PubMed ID: 30647957
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the effect of erythropoietin + corticosteroid versus corticosteroid alone in methanol-induced optic nerve neuropathy.
Zamani N; Hassanian-Moghaddam H; Shojaei M; Rahimian S
Cutan Ocul Toxicol; 2018 Jun; 37(2):186-190. PubMed ID: 28849680
[TBL] [Abstract][Full Text] [Related]
17. Visual Outcome after Treatment with High Dose Intravenous Methylprednisolone in Indirect Traumatic Optic Neuropathy.
Pokharel S; Sherpa D; Shrestha R; Shakya K; Shrestha R; Malla OK; Pradhananga CL; Pokhrel RP; Shrestha P
J Nepal Health Res Counc; 2016 Jan; 14(32):1-6. PubMed ID: 27426704
[TBL] [Abstract][Full Text] [Related]
18. Risk factors affecting the visual outcome in patients with indirect traumatic optic neuropathy.
Sefi-Yurdakul N; Koç F
Int Ophthalmol; 2018 Aug; 38(4):1647-1652. PubMed ID: 28681279
[TBL] [Abstract][Full Text] [Related]
19. Low-dose intravenous methylprednisolone or conservative treatment in the management of traumatic optic neuropathy.
Yip CC; Chng NW; Au Eong KG; Heng WJ; Lim TH; Lim WK
Eur J Ophthalmol; 2002; 12(4):309-14. PubMed ID: 12220002
[TBL] [Abstract][Full Text] [Related]
20. Analysis of Retinal Layer Thicknesses and Their Clinical Correlation in Patients with Traumatic Optic Neuropathy.
Lee JY; Cho K; Park KA; Oh SY
PLoS One; 2016; 11(6):e0157388. PubMed ID: 27295139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
